These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2575179)
41. Effects of antihypertensive drugs on atherogenic factors: possible importance of drug selection in prevention of atherosclerosis. Spence JD J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S121-5. PubMed ID: 2409360 [TBL] [Abstract][Full Text] [Related]
42. Terazosin: a new alpha adrenoceptor blocking drug. Achari R; Laddu A J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083 [TBL] [Abstract][Full Text] [Related]
43. Effect of terazosin on blood pressure and serum lipids. Gong P; Tang J; Cheng L; Lu Z; Zhang J; Zeng F J Tongji Med Univ; 1999; 19(4):291-4. PubMed ID: 12938521 [TBL] [Abstract][Full Text] [Related]
44. Effect of terazosin on serum lipids. Deger G Am J Med; 1986 May; 80(5B):82-5. PubMed ID: 2872813 [TBL] [Abstract][Full Text] [Related]
45. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction. Taylor SH Am Heart J; 1988 Dec; 116(6 Pt 2):1735-47. PubMed ID: 2904744 [TBL] [Abstract][Full Text] [Related]
46. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks. Saunders E Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925 [TBL] [Abstract][Full Text] [Related]
47. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension. Frishman WH; Eisen G; Lapsker J Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488 [TBL] [Abstract][Full Text] [Related]
48. [Recent trend in the research of hypertension in Japan. The effects of antihypertensive drugs on serum lipids and lipoproteins in patients with mild to moderate hypertension]. Goto Y; Tamachi H Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1820-5. PubMed ID: 2907996 [No Abstract] [Full Text] [Related]
49. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension. Overlack A; Stumpe KO J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798 [TBL] [Abstract][Full Text] [Related]
50. Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitor. Chrysant SG; Bal IS; Johnson B; McPherson MA Clin Cardiol; 1985 Sep; 8(9):486-9. PubMed ID: 2864153 [TBL] [Abstract][Full Text] [Related]
52. Effects of prazosin on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease: hypertension and other risk factors, Milan, 1983. Lowenstein J Am J Cardiol; 1984 Jan; 53(3):21A-23A. PubMed ID: 6141723 [TBL] [Abstract][Full Text] [Related]
54. Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events. Somberg JC; Achari R; Laddu AR Am Heart J; 1991 Sep; 122(3 Pt 2):901-5. PubMed ID: 1678920 [TBL] [Abstract][Full Text] [Related]
55. Alpha-1 blockers. A new generation of antihypertensive agents. Humphreys JE; Waite MA J Clin Pharm Ther; 1989 Aug; 14(4):263-83. PubMed ID: 2571616 [TBL] [Abstract][Full Text] [Related]
56. The cardiovascular effects of alpha-receptor blocking agents. Leren P J Hypertens Suppl; 1992 Jun; 10(3):S11-4; discussion S14-5. PubMed ID: 1353110 [TBL] [Abstract][Full Text] [Related]
59. Blood pressure-lowering effect of adding grapefruit juice to nifedipine and terazosin in a patient with severe renovascular hypertension. Pisarik P Arch Fam Med; 1996; 5(7):413-6. PubMed ID: 8665000 [TBL] [Abstract][Full Text] [Related]
60. Doxazosin for treatment of hypertension. Med Lett Drugs Ther; 1991 Feb; 33(838):15-6. PubMed ID: 1825232 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]